We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting.
Marc Dechamps, CEO of Bioxodes, will give a presentation as part of the ‘Autoimmune, Inflammation and Thrombosis’ track.
The presentation, titled: ‘Bioxodes, a clinical stage company developing a first-in-class drug candidate against thrombosis and neuroinflammation starting with Hemorrhagic Stroke’, will be held in the Liffey meeting room on May 15, at 11:18am IST. The presentation will also be available on BioCentury’s partneringONE® platform.